TMEM219 regulates the transcription factor expression and proliferation of beta cells
Pancreatic beta cells replenishment is considered the next therapeutic option for type 1 diabetes; while stimulating endogenous beta cells proliferation is the “holy grail” for those patients with exhausted beta cell mass. Here we are demonstrating that the pro-apoptotic receptor TMEM219 is expresse...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2024-01-01
|
| Seri Bilgileri: | Frontiers in Endocrinology |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1306127/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|